In search of FDA Approval effect
$2seventy bio (TSVT.US)$ analyst target price 8.2
$OptiNose (OPTN.US)$ all analysts target price 3
$Arcutis Biotherapeutics (ARQT.US)$ avg target price 9.6 (low 4, high 20)
Some of its chart show something good is going to happen, hope no more prank coming from these.
Vanguard and Blackrock also added position on September... ARQT has Vanguard only added position...
still have to wait FDA result though, nothing can be assured. the FDA tracker dot com only provide the schedule, the result is still unknown. hope all of them got approval.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Massinooo : When are the approval dates?
Joy Boy or Bringer OP Massinooo : the meeting was held on 16 December... according to FDA Tracker dot com... but it's not sure whether it's going to be approved or not... another user in MooMoo also said it's going to be on 16th... you can check @Meltyy post...
Massinooo Joy Boy or Bringer OP : Thanks for the info!
Joy Boy or Bringer OP Massinooo : This is the info from the website, but you know last time $Brainstorm Cell Therapeutics (BCLI.US)$ was scheduled in the website for FDA approval however it's turned up to be Phase 3B...